Zocto News
Category

News

2424 posts · page 82 of 101

Measles Vaccine Remains Effective, Says icddr,b Report
News

Measles Vaccine Remains Effective, Says icddr,b Report

The icddr,b confirms that the measles vaccine continues to offer robust protection against the virus.

Study Confirms COVID-19 Vaccine Estimates Unbiased by Healthy Vaccinee Effect
News

Study Confirms COVID-19 Vaccine Estimates Unbiased by Healthy Vaccinee Effect

New research shows COVID-19 vaccine effectiveness estimates remain accurate, unaffected by the healthy vaccinee effect.

Innovative Vaccine Targets Leading Cause of Fatal Diarrheal Disease
News

Innovative Vaccine Targets Leading Cause of Fatal Diarrheal Disease

A groundbreaking vaccine aims to combat a major source of deadly diarrheal disease, offering hope for millions worldwide.

Decentralized Healthcare: Hospitals Without Walls Transform Patient Care
News

Decentralized Healthcare: Hospitals Without Walls Transform Patient Care

Hospitals are breaking traditional boundaries, offering advanced care directly in patient homes through telehealth and mobile units.

Philips Advances Remote Patient Monitoring with Expanded Ecosystem
News

Philips Advances Remote Patient Monitoring with Expanded Ecosystem

Philips enhances its patient monitoring system, enabling healthcare providers to track patients outside traditional settings.

SDH Nubra Enhances Palliative Care with Expanded Services
News

SDH Nubra Enhances Palliative Care with Expanded Services

SDH Nubra in Ladakh offers comprehensive palliative care both in hospitals and at patients' homes.

Lilly's Olomorasib Gains FDA Breakthrough Status for KRAS G12C Pancreatic Cancer
News

Lilly's Olomorasib Gains FDA Breakthrough Status for KRAS G12C Pancreatic Cancer

Eli Lilly's olomorasib receives FDA Breakthrough Therapy status for advanced pancreatic cancer treatment targeting KRAS G12C mutation.

WHO Declares IPC as Southeast Asia's Centre of Excellence
News

WHO Declares IPC as Southeast Asia's Centre of Excellence

The WHO SEARN has designated India's IPC as a Regional Centre of Excellence for its outstanding contributions to public health.

India's Pharmaceutical Sector Grapples with Drug Safety Challenges
News

India's Pharmaceutical Sector Grapples with Drug Safety Challenges

Amid global scrutiny, India's pharma industry prioritizes drug safety to ensure compliance and protect public health.

Hypotension Alert: IPC Links Adverse Reaction to Polymyxin B
News

Hypotension Alert: IPC Links Adverse Reaction to Polymyxin B

The IPC has flagged hypotension as a suspected adverse reaction to Polymyxin B, raising safety concerns.

Goa Pharmacies to Close on May 20 in E-Pharmacy Protest
News

Goa Pharmacies to Close on May 20 in E-Pharmacy Protest

Pharmacies across Goa will shut for a day on May 20 to protest against e-pharmacies, citing unfair competition.

India's Online Pharmacy Surge Raises Concerns Over Unregulated Drugs
News

India's Online Pharmacy Surge Raises Concerns Over Unregulated Drugs

India's online pharmacy market is booming, but concerns grow over the risks of unregulated medication sales.

Tata 1mg Maintains Strategic Course Amidst E-Pharmacy Competition
News

Tata 1mg Maintains Strategic Course Amidst E-Pharmacy Competition

Tata 1mg remains steadfast in its strategy, resisting industry pressures in the competitive e-pharmacy sector.

AI Innovations Enhance Opioid Safety for Elderly Patients
News

AI Innovations Enhance Opioid Safety for Elderly Patients

AI tools are being developed to manage opioid risks in older adults, aiming to reduce misuse and improve healthcare outcomes.

Real-Time Prescription Monitoring Curbs High-Risk Meds: Australian Study
News

Real-Time Prescription Monitoring Curbs High-Risk Meds: Australian Study

Monash University study finds real-time monitoring reduces high-risk drug prescriptions.

India Tightens Controls on Pregabalin Prescriptions Amid Concerns
News

India Tightens Controls on Pregabalin Prescriptions Amid Concerns

India's Health Ministry mandates stricter prescription controls for pregabalin to curb misuse and addiction.

FDA Recognizes Zocilurtatug Pelitecan as Orphan Drug for Rare Cancers
News

FDA Recognizes Zocilurtatug Pelitecan as Orphan Drug for Rare Cancers

The FDA has granted orphan drug status to Zocilurtatug Pelitecan for treating neuroendocrine carcinomas, offering new hope for patients with this rare cancer.

FDA Awards Orphan Drug Status to Experimental ALL Treatment
News

FDA Awards Orphan Drug Status to Experimental ALL Treatment

The FDA has designated a new therapy for acute lymphoblastic leukemia as an orphan drug, potentially accelerating its development.

Tata Memorial Launches Major Breast Cancer Genome Sequencing Initiative
News

Tata Memorial Launches Major Breast Cancer Genome Sequencing Initiative

Tata Memorial Centre embarks on a large-scale genome sequencing project to tackle breast cancer, aiming to enhance treatment and prevention strategies.

Whole Genome Sequencing Market Growth Driven by Technological Advances
News

Whole Genome Sequencing Market Growth Driven by Technological Advances

The whole genome sequencing market is set for significant growth, fueled by technological innovations and increased demand for personalized medicine.

Whole-Genome Sequencing Uncovers De Novo Mutation Patterns
News

Whole-Genome Sequencing Uncovers De Novo Mutation Patterns

A comprehensive study highlights the prevalence and impact of de novo mutations on human health.

Undisclosed Death in China Gene-Editing Trial Sparks Concerns
News

Undisclosed Death in China Gene-Editing Trial Sparks Concerns

A girl's death in a Chinese gene-editing trial raises ethical concerns as the industry rapidly expands.

Gene-Edited Beagles Offer Allergy-Free Companionship
News

Gene-Edited Beagles Offer Allergy-Free Companionship

Researchers have developed gene-edited beagles that don't cause allergies, though applicability to cats remains uncertain.

Gene Editing Trial in China Ends in Tragic Patient Death
News

Gene Editing Trial in China Ends in Tragic Patient Death

A patient in a Chinese gene editing trial has died, raising safety concerns in the biotech field.